---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-001958"
form_type: "8-K"
ticker: "CTOR"
cik: "0001851484"
company_name: "CITIUS ONCOLOGY, INC."
filed_at: "2024-01-10T23:59:59+00:00"
generated_at: "2026-06-07T01:04:47.064131+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# TenX Keane Acquisition files proxy supplement for extension; sponsor to fund trust for up to 10-month extension

## Summary
- Extraordinary general meeting on Jan 17, 2024 to vote on extension amendment.
- If approved, sponsor will contribute up to $200k or $0.10/share for first 3-month extension.
- For subsequent monthly extensions, sponsor contributes up to $66,667 or $0.03/share per month.
- Extensions could extend deadline from Jan 18, 2024 to as late as Nov 18, 2024.
- Loans are non-interest bearing and repayable upon business combination.

## SEC filing metadata
- accession: 0001493152-24-001958
- form_type: 8-K
- ticker: CTOR
- cik: 0001851484
- company_name: CITIUS ONCOLOGY, INC.
- filed_at: 2024-01-10T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1851484/000149315224001958/0001493152-24-001958-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1851484/000149315224001958/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-001958
- JSON: https://secwatch.observer/filing/0001493152-24-001958.json
- Plain text: https://secwatch.observer/filing/0001493152-24-001958.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.